Exosomes from breast cancer cells stimulate proliferation and inhibit apoptosis of CD133+ cancer cells in vitro

被引:25
|
作者
Shi, Jianhua [1 ]
Ren, Yi [1 ]
Zhen, Linlin [1 ]
Qiu, Xiaolan [1 ]
机构
[1] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Breast & Thyroid Surg, Huaian 223001, Jiangsu, Peoples R China
关键词
exosomes; breast cancer; CD133; TUMOR-DERIVED EXOSOMES; T-CELLS; MICROVESICLES;
D O I
10.3892/mmr.2014.2749
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Exosomes are a family of bioactive vesicles that are secreted from various types of cell, including tumor cells. Exosomes derived from breast cancer cells have been demonstrated to perform important functions in tumor progression in vitro and in vivo. However, few studies exist regarding the function of exosomes in CD133(+) breast cancer cells. In the present study, exosomes from 4T1 mouse breast cancer cells and mouse mammary gland epithelial cells were purified. The exosome-associated markers CD63, CD9 and CD81 were detected, and the size distribution and potential of the exosomes were determined. Exosome uptake by CD133(+) and CD133(-) 4T1 cells was confirmed by confocal microscopy. An ATPlite assay indicated that the proliferation of CD133(+) cells was increased and the apoptosis was suppressed by exosomes from 4T1 cells. Collectively, the findings of the present study demonstrate a novel mechanism by which the action of exosomes on CD133(+) 4T1 cells may contribute to breast cancer progression.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 50 条
  • [1] CD133+ cancer stem cells in lung cancer
    Wang, Shuang
    Xu, Zhen Ye
    Wang, Li Fang
    Su, Wan
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 447 - 453
  • [2] CD133+ and CD133- Cancer stem cells in glioblastoma
    Beier, D.
    Hau, P.
    Proescholdt, M.
    Lohmeier, A.
    Aigner, L.
    Brawanski, A.
    Bogdahn, U.
    Beier, C. P.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 317 - 317
  • [3] Cisplatin selects for CD133+ cells in lung cancer cells
    Jiaheng Li
    Mei Jiang
    Xiaoting Zhao
    Ziyu Wang
    Meng Gu
    Weiying Li
    [J]. Oncology and Translational Medicine, 2020, 6 (01) : 16 - 20
  • [4] CD133+ Cells Are Resistant to Anoikis in Pancreatic Cancer
    Moriyama, T.
    Ohuchida, K.
    Lin, C.
    Ikenaga, N.
    Sakai, H.
    Mizumoto, K.
    Tanaka, M.
    [J]. PANCREAS, 2009, 38 (08) : 1029 - 1029
  • [5] Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
    T Baba
    P A Convery
    N Matsumura
    R S Whitaker
    E Kondoh
    T Perry
    Z Huang
    R C Bentley
    S Mori
    S Fujii
    J R Marks
    A Berchuck
    S K Murphy
    [J]. Oncogene, 2009, 28 : 209 - 218
  • [6] The Role of Cancer Stem Cells (CD133+) in Malignant Gliomas
    Cho, Der-Yang
    Lin, Shinn-Zong
    Yang, Wen-Kuang
    Hsu, Den-Mei
    Lin, Hung-Lin
    Lee, Han-Chung
    Lee, Wen-Yeun
    Chiu, Shao-Chih
    [J]. CELL TRANSPLANTATION, 2011, 20 (01) : 121 - 125
  • [7] Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma
    Yang Jing-pu
    Liu Yan
    Zhong Wei
    Yu Dan
    Wen Lian-ji
    Jin Chun-shun
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (07) : 1055 - 1060
  • [8] Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma
    YANG Jingpu
    LIU Yan
    ZHONG Wei
    YU Dan
    WEN Lianji
    JIN Chunshun
    [J]. 中华医学杂志(英文版), 2011, (07) : 1055 - 1060
  • [9] CHARACTERIZATION AND IMAGING OF CD133+ LIVER CANCER STEM CELLS
    Suetsugu, A.
    Osawa, Y.
    Aoki, H.
    Kunisada, T.
    Tsurumi, H.
    Hoffman, R. M.
    Moriwaki, H.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S445 - S446
  • [10] Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
    Suetsugi, Atsushi
    Nagaki, Masahito
    Aoki, Hitomi
    Motohashi, Tsutomu
    Kunisada, Takahiro
    Moriwaki, Hisataka
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 351 (04) : 820 - 824